• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problems High Test Results (2457); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Ischemia Stroke (4418)
Event Date 11/04/2023
Event Type  Injury  
Event Description
We received an allegation that a coaguchek xs meter may have contributed to a patient's alleged stroke caused by a blood clot in the brain and that the same meter gave a questionable inr result when the result was compared with an unknown laboratory method.On (b)(6) 2023, the meter result was reportedly 2.6 inr.On (b)(6) 2023, the patient reportedly had stroke symptoms: the left side of her body was partially paralyzed, slurred speech, and was unable to move her left arm.She reportedly went to the emergency room (er).Upon arrival at the hospital, the laboratory result from an unknown method was reportedly 1.2 inr.Magnetic resonance imaging (mri) and computed tomography (ct) scans were reportedly performed.The results allegedly showed a blood clot in the brain (the patient did not know which side).The patient reportedly had surgery to remove the blood clot.The patient was allegedly on a heparin drip and warfarin while in the hospital.She was reportedly on 3 mg of warfarin before the blood clot occurred and was reportedly on 14 mg of warfarin when she left the hospital.The patient was allegedly in the hospital for 12 days and reportedly did not have any lasting effects from the stroke.The patient reportedly had only one blood clot in the brain and no other blood clots were found.On (b)(6) 2023: the result from an unknown laboratory method at 10:00 am using a venous blood sample was reportedly 4.1 inr.The meter result at 11:00 am using a fingerstick blood sample was reportedly 5.6 inr.The patient's warfarin dose was reportedly lowered from 14 mg to 11 mg daily based on the laboratory result.The patient's therapeutic range is reportedly 2.0 to 3.0 inr with an alleged testing frequency of weekly.The patient is reportedly currently "feeling good." this mdr is being submitted in an abundance of caution.
 
Manufacturer Narrative
The coaguchek xs meter serial number was (b)(6).The products were requested for investigation.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and the results have passed the internal inspection.Section e3 - occupation: patient/consumer.
 
Manufacturer Narrative
The customer's products were not received for investigation.Per product labeling, "coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods." the investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key18377282
MDR Text Key331184016
Report Number1823260-2023-04167
Device Sequence Number1
Product Code GJS
UDI-Device Identifier00365702127104
UDI-Public00365702127104
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 01/10/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date03/31/2024
Device Catalogue Number04625374160
Device Lot Number64708121
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/24/2023
Initial Date FDA Received12/21/2023
Supplement Dates Manufacturer Received12/22/2023
Supplement Dates FDA Received01/10/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
WARFARIN
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age33 YR
Patient SexFemale
Patient Weight125 KG
-
-